Your browser doesn't support javascript.
loading
Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.
Light, Gregory A; Swerdlow, Neal R; Thomas, Michael L; Calkins, Monica E; Green, Michael F; Greenwood, Tiffany A; Gur, Raquel E; Gur, Ruben C; Lazzeroni, Laura C; Nuechterlein, Keith H; Pela, Marlena; Radant, Allen D; Seidman, Larry J; Sharp, Richard F; Siever, Larry J; Silverman, Jeremy M; Sprock, Joyce; Stone, William S; Sugar, Catherine A; Tsuang, Debby W; Tsuang, Ming T; Braff, David L; Turetsky, Bruce I.
Afiliação
  • Light GA; Department of Psychiatry, University of California San Diego, La Jolla, CA, United States; VISN-22 Mental Illness, Research, Education and Clinical Center (MIRECC), VA San Diego Healthcare System, United States. Electronic address: glight@ucsd.edu.
  • Swerdlow NR; Department of Psychiatry, University of California San Diego, La Jolla, CA, United States.
  • Thomas ML; Department of Psychiatry, University of California San Diego, La Jolla, CA, United States.
  • Calkins ME; Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, United States.
  • Green MF; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, United States; VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States.
  • Greenwood TA; Department of Psychiatry, University of California San Diego, La Jolla, CA, United States.
  • Gur RE; Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, United States.
  • Gur RC; Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, United States.
  • Lazzeroni LC; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States.
  • Nuechterlein KH; Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, United States.
  • Pela M; Department of Psychiatry, University of California San Diego, La Jolla, CA, United States.
  • Radant AD; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States; VA Puget Sound Health Care System, Seattle, WA, United States.
  • Seidman LJ; Department of Psychiatry, Harvard Medical School, Boston, MA, United States; Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess Medical Center, Boston, MA, United States.
  • Sharp RF; Department of Psychiatry, University of California San Diego, La Jolla, CA, United States.
  • Siever LJ; Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, United States; James J. Peters VA Medical Center, New York, NY, United States.
  • Silverman JM; Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, United States; James J. Peters VA Medical Center, New York, NY, United States.
  • Sprock J; Department of Psychiatry, University of California San Diego, La Jolla, CA, United States.
  • Stone WS; Department of Psychiatry, Harvard Medical School, Boston, MA, United States; Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess Medical Center, Boston, MA, United States.
  • Sugar CA; Department of Biostatistics, University of California Los Angeles School of Public Health, Los Angeles, CA, United States.
  • Tsuang DW; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States; VA Puget Sound Health Care System, Seattle, WA, United States.
  • Tsuang MT; Department of Psychiatry, University of California San Diego, La Jolla, CA, United States; Center for Behavioral Genomics, and Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, United States; Harvard Institute of Psychiatric Epidemiology and Genetics, Boston, MA, Unit
  • Braff DL; Department of Psychiatry, University of California San Diego, La Jolla, CA, United States.
  • Turetsky BI; Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, United States.
Schizophr Res ; 163(1-3): 63-72, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25449710
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Percepção Auditiva / Encéfalo / Potenciais Evocados P300 / Potenciais Evocados Auditivos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Schizophr Res Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Percepção Auditiva / Encéfalo / Potenciais Evocados P300 / Potenciais Evocados Auditivos Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Schizophr Res Ano de publicação: 2015 Tipo de documento: Article